PROBLEM TO BE SOLVED: To provide a new compound having fibroblast growth factor receptor (FGFR) inhibitory action, and a pharmaceutical composition containing the same.SOLUTION: The present invention provides a compound represented by formula (I) or pharmaceutically acceptable salt thereof [A is a C6-10 arylene group J is a C3-10 nitrogen-containing nonaromatic heterocyclic group that may have one-three substituent selected from a substituent group L, or the like R1, R2, and R3 are a hydrogen atom or the like R4 is a C1-6 alkyl group R5 is a hydroxy C1-6 alkyl group that may be substituted with one-three halogen atom, or the like R6, R7, R8, R9, and R10 are a hydrogen atom or the like the substituent group L is a group consisting of a C1-6 alkyl group and the like].SELECTED DRAWING: NoneCOPYRIGHT: (C)2018,JPO&INPIT【課題】線維芽細胞成長因子受容体(FGFR)阻害作用を有する新たな化合物及びそれらを含有する医薬組成物の提供。【解決手段】次式(I)で表される化合物またはその薬剤学的に許容される塩。[Aは、C6-10アリーレン基;Jは、置換基群Lから選ばれる置換基を1~3個有していてもよいC3-10含窒素非芳香族ヘテロ環式基等;R1、R2、R3は、水素原子等;R4は、C1-6アルキル基;R5は、1~3個のハロゲン原子で置換されてもよいヒドロキシC1-6アルキル基等;R6、R7、R8、R9、及びR10は、水素原子等;置換基群Lは、C1-6アルキル基等からなる群を表す]【選択図】なし
